Answers are grounded in this paper and cite their sources.
Excessive reactive oxygen and nitrogen species cause oxidative stress, leading to a variety of chronic illnesses, highlighting the need for new antioxidants. This study applied a chemoinformatics approach to eleven 1-naphthol derivatives to elucidate their binding mode to human peroxiredoxin 5 (PDB ID: 1HD2), free-radical scavenging mechanisms, and pharmacokinetic profiles. Ligands were optimized at the B3LYP/6-311G(d) level and docked using Molegro Virtual Docker. Thermodynamic parameters for the hydrogen-atom transfer (HAT), single-electron transfer–proton transfer (SET-PT), and sequential proton-loss electron transfer (SPLET) pathways were computed, together with global reactivity descriptors. ADME-Tox and drug-likeness properties were predicted with Swiss ADME and pk CSM. Compounds 8, 6, and 11 exhibited the strongest binding affinities (-88.98, -86.20, and -84.72 kcal mol-1, respectively) and formed key interactions with ALA90, ARG86, and LEU96. Bond-dissociation enthalpies (291.8–304.6 kJ mol-1) indicated that the HAT mechanism is thermodynamically preferred over SET-PT and SPLET. Compound 11 displayed the narrowest HOMO–LUMO gap and lowest chemical hardness. All three candidates complied with Lipinski’s rule of five, showed high intestinal absorption (> 91 %), and lacked predicted hepatotoxicity. These results identify selected 1-naphthol derivatives as promising antioxidant leads that combine target engagement, favorable radical-scavenging thermodynamics, and acceptable pharmacokinetic properties.
No takes yet. Share an insight, caveat, or question.
Muhammad et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: